Ultragenyx Pharma (RARE) PT Lowered to $45 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Ben Burnett lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $45.00 (from $65.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
